Evidence map›Paper›PMID 36622672›Full record

ArticleJAMA network open2023

Evaluation of the Association Between Congenital Cytomegalovirus Infection and Pediatric Acute Lymphoblastic Leukemia.

Jennifer M Geris, Mark R Schleiss, Anthony J Hooten, Erica Langer, Nelmary Hernandez-Alvarado, Michelle A Roesler, Jeannette Sample, Lindsay A Williams, David S Dickens, Rajen J Mody and 5 more

Open access · goldAbstract read
In one paragraph

Article in JAMA network open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. A vaccine against cytomegalovirus: how close are we?The Journal of clinical investigation · 2025
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 1 country.

Jennifer M GerisDivision of Epidemiology and Clinical Research, Department of Pediatrics, University of Minnesota, Minneapolis.
Mark R SchleissInstitute for Molecular Virology, University of Minnesota, Minneapolis.
Anthony J HootenMasonic Cancer Center, University of Minnesota, Minneapolis.
Erica LangerMasonic Cancer Center, University of Minnesota, Minneapolis.
Nelmary Hernandez-AlvaradoDivision of Pediatric Infectious Diseases, Department of Pediatrics, University of Minnesota, Minneapolis.
Michelle A RoeslerDivision of Epidemiology and Clinical Research, Department of Pediatrics, University of Minnesota, Minneapolis.
Jeannette SampleDivision of Epidemiology and Clinical Research, Department of Pediatrics, University of Minnesota, Minneapolis.
Lindsay A WilliamsDivision of Epidemiology and Clinical Research, Department of Pediatrics, University of Minnesota, Minneapolis.
David S DickensDivision of Hematology/Oncology/Bone Marrow Transplantation, Department of Pediatrics, University of Iowa, Iowa City.
Rajen J ModyDivision of Hematology-Oncology, Department of Pediatrics, Michigan Medicine, Ann Arbor.
Yaddanapudi RavindranathDivision of Hematology/Oncology, Department of Pediatrics, Wayne State University School of Medicine, and Children's Hospital of Michigan, Detroit.
Kate L GowansDepartment of Pediatric Hematology/Oncology, Beaumont Health, Royal Oak, Michigan.
Matthew G PridgeonCenter for Cancer and Cell Biology, Van Andel Research Institute, Grand Rapids, Michigan.
Logan G SpectorDivision of Epidemiology and Clinical Research, Department of Pediatrics, University of Minnesota, Minneapolis.
Heather H NelsonMasonic Cancer Center, University of Minnesota, Minneapolis.
University of Minnesota · USBeaumont Health · USChildren's Hospital of Michigan · USMichigan Medicine · USUniversity of Iowa · USVan Andel Institute · US

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Christopher K Laubenthal · 2000 to 2026
$70.0M
Minnesota Training Program in VirologyT32AI083196 · NIAID · UNIVERSITY OF MINNESOTA · PI Louis M Mansky · 2010 to 2026
$3.2M
Congenital cytomegalovirus infection, KIR genotypes, and acute lymphoblastic leukemiaR01CA228478 · NCI · UNIVERSITY OF MINNESOTA · PI NELSON, HEATHER HAMMOND, SPECTOR, LOGAN G. · 2018 to 2020
$1.7M
NCI NIH HHS R01 CA228478NIAID NIH HHS T32 AI083196
6 · The paper itself

Abstract

Importance: Acute lymphoblastic leukemia (ALL) is the most common form of pediatric cancer, and a leading cause of death in children. Understanding the causes of pediatric ALL is necessary to enable early detection and prevention; congenital cytomegalovirus (cCMV) has recently been identified as a potential moderate-to-strong factor associated with risk for ALL. Objective: To compare the prevalence of cCMV infection between ALL cases and matched controls. Design, Setting, and Participants: In this population-based case-control study of ALL cases and matched controls, cases consisted of children aged 0 to 14 years between 1987 and 2014 with an ALL diagnosis identified through the Michigan Cancer Surveillance Program and born in Michigan on or after October 1, 1987. Cancer-free controls were identified by the Michigan BioTrust for Health and matched on age, sex, and mother's race and ethnicity. Data were analyzed from November to May 2022. Exposures: cCMV infection measured by quantitative polymerase chain reaction in newborn dried blood spots. Main Outcomes and Measures: ALL diagnosed in children aged 0 to 14 years. Results: A total of 1189 ALL cases and 4756 matched controls were included in the study. Bloodspots were collected from participants at birth, and 3425 (57.6%) participants were male. cCMV was detected in 6 ALL cases (0.5%) and 21 controls (0.4%). There was no difference in the odds of cCMV infection comparing ALL cases with controls (odds ratio, 1.30; 95% CI, 0.52-3.24). Immunophenotype was available for 536 cases (45.1%) and cytogenetic data for 127 (27%). When stratified by subtype characteristics, hyperdiploid ALL (74 cases) was associated with 6.26 times greater odds of cCMV infection compared with unmatched controls (95% CI, 1.44-27.19). Conclusions and Relevance: In this case-control study of cCMV and pediatric ALL, cCMV was associated with increased risk of hyperdiploid ALL. These findings encourage continued research.

Indexed as

Cytomegalovirus InfectionsPrecursor Cell Lymphoblastic Leukemia-LymphomaCase-Control StudiesChildFemaleHumansInfant, NewbornMaleMichiganPrevalence

Identifiers

PMID36622672
PMCPMC9856744
OpenAlexW4313857782

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.